Authors:
Nakamura, T
Ohno, M
Tabuchi, Y
Kamigaki, T
Fujii, H
Yamagishi, H
Kuroda, Y
Citation: T. Nakamura et al., Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III, INT J ONCOL, 19(2), 2001, pp. 291-298
Authors:
Habara, K
Ajiki, T
Kamigaki, T
Nakamura, T
Kuroda, Y
Citation: K. Habara et al., High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro, JPN J CANC, 92(10), 2001, pp. 1127-1132
Authors:
Ajiki, T
Kamigaki, T
Hasegawa, Y
Fujino, Y
Suzuki, Y
Takeyama, Y
Ku, Y
Kuroda, Y
Citation: T. Ajiki et al., Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of vater, HEP-GASTRO, 48(41), 2001, pp. 1266-1270
Authors:
Suzuki, Y
Ku, Y
Tominaga, M
Kamigaki, T
Fujino, Y
Tanioka, Y
Iwasaki, T
Fukumoto, T
Takeyama, Y
Kuroda, Y
Citation: Y. Suzuki et al., Two-staged treatment with local resection and percutaneous isolated hepatic chemoperfusion for advanced pancreatic cancer with multiple liver metastases: Report of a case, HEP-GASTRO, 48(38), 2001, pp. 574-577
Authors:
Kamigaki, T
Ajiki, T
Yamamoto, M
Kuroda, Y
Citation: T. Kamigaki et al., Enhancement of tumor uptakes by stabilized Fab homo-oligomers of a chimeric monoclonal antibody against carcinoembryonic antigen, INT J ONCOL, 14(1), 1999, pp. 139-144